 Enveric Biosciences NASDAQ:ENVB Inc said it has priced its previously-announced underwritten public offering of 20 million company common shares plus warrants to purchase up to an additional 20 million shares of its common stock, for expected gross proceeds of 10 million. Enveric noted that each common share is being sold at a price of 0.50, with each warrant enabling the holder to purchase an additional share of the company at a price of 0.55. 